Table 1

Clinical and genotypic information in 27 Chinese patients with TCIRG1-related IMO

CaseSexAge at
onset*
Mutation in TCIRG1
gene
EffectSourceGaze
qualities
Optic
atrophy
Optic canal
diameter (mm)
FVEP
RLRL
1M1c.1228G>T/c.2218-2219delCTp.G410RParentsNo1.61.6WW
2F1c.1837-1840delATGT/IVS15+1G>ADeletion of frameshiftParentsNYes1.21.3WW
3M2c.2181C>Ap.C727XMotherNRMNo1.71.3WF
4M1c.2161-2163ATC delp.I721delMotherNRLYes1.21.3FF
5M1IVS13,-2A>Cp.Q372XMotherNRMNo1.10.9FF
6M5IVS15,+1G>ADeletion of splicing siteParentsNo1.91.8WW
7M4c.796G>T/c.1372G>Ap.E266X/p.G458SParentsNo1.61.5WW
8M2c.1019-c.1020:ins GGTGA/c.65(E2):delCp.340,S>Sfs151/p.22,A>Afs5ParentsN, SYes1.51.5WW
9F1IVS3,+5G>A/IVS4,-21A>G/ParentsN, SYes1.71.7WW
10M6c.1213G>A/c.2218-2219delCTp.G405RParentsNYes1.471.52WW
11F7c.685G>T/c.1897C>Tp.G229X/p.Q633XParentsNNo1.71.7WW
12F3c.1188delC/c.2008C>Tp.P397Pfs6/p.R670XParentsNNo2.22.3FF
13F4c.C649-1297Large segment protein deletionFatherNo4.13.8WW
14M4c.2008C>T(E16)p.670,R>X(161)FatherNYes21.7FF
15F3c.475dupG/c.1372G>Ap.P158fs/p.G458sParentsN, SYes1.961.81FF
16F2c.1036_1037insGTGC/c.1188delCp.V348Cfs*143/p.F398Sfs*5ParentsSNo1.11.0WW
17M2c.1213G>Ap.G405RParentsNo2.82.6WW
18F6c.117+5G>A/c.630G>A/ParentsNo2.52.7WW
19M0c.1007_1013del/c.1015A>T/c.1213G>Ap.L336Pfs*8/p.S339C/p.G405RParentsNRL, NYes1.31.5FF
20F6c.1775G>A/IVS13,-2A>Cp.W592XParentsSYes1.241.56WW
21M3c.1733T>G/c.2008C>Tp.L578R/p.R670XParentsNRM, NNo1.71.3WW
22F0c.1213G>A/c.196+5G>Ap.(Gly405Arg)/p./ParentsSNo1.51.6WW
23M1c.1370delCp.T457Tfs*71ParentsSYes1.81.4WW
24M2c.1114C>T/c.196+5G>Ap.(Gln372*) /p./ParentsNo1.11.2WW
25M1c.1371delCp.Thr457fsParentsN, SYes1.01.0FF
26F0.2c.1371delCp.Thr457fsParentsNRL, SNo1.21.1WW
27M17c.1114C>T/c.2008C>Tp.Q372X/p.R670XParentsNo2.02.0WW
  • *Month.

  • /, 'no change in amino acids'; F, flat wave; FVEP, Flash visual-evoked potential; IMO, infantile malignant osteopetrosis; L, left; N, nystagmus; NRL, no response to light; NRM, no response to moving; R, right; S, strabismus; TCIRG1, T-cell immune regulator 1; W, waveform.